The North America Intraosseous Infusion Devices Market would witness market growth of 5.2% CAGR during the forecast period (2024-2031).
The US market dominated the North America Intraosseous Infusion Devices Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $397.7 Million by 2031. The Canada market is experiencing a CAGR of 7.6% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 6.7% during (2024 - 2031).
The adoption of these devices has been propelled by their ability to provide rapid and reliable vascular access, particularly in life-threatening situations such as cardiac arrest, trauma, and pediatric emergencies. Intraosseous access offers several advantages over traditional vascular access methods, including bypassing collapsed veins, achieving rapid drug delivery, and maintaining vascular access in hypovolemic or hemodynamically unstable patients.
Moreover, the increasing expansion and development of healthcare facilities are expected to boost the demand for these devices significantly. As per the data provided in 2023 by the Government of Canada, to enhance health care services for Canadians, the government announced an investment of $196.1 billion over ten years, including $46.2 billion in new funding, for provinces and territories.
Mexico has been investing in expanding its hospital infrastructure to meet the growing healthcare needs of its population. With the construction of new hospitals and the expansion of existing facilities, there is a greater demand for essential medical equipment, including these devices, to support emergency and critical care services. As per the data from the Government of Mexico, in the fourth quarter of 2023, health care and social assistance recorded a gross domestic product of $577B MX. Moreover, with advancing age comes a higher prevalence of age-related health conditions, such as cardiovascular disease, sepsis, dehydration, and respiratory distress, among the elderly population in Canada. As per Statistics Canada, in 2022, there were 7,330,605 people aged 65 and older in Canada. The 2021 Census recorded a total of 861,000 individuals aged 85 and above, which is over twofold the figure reported in the 2001 Census. Hence, the rising healthcare sector and aging population in North America will assist in the expansion of the regional market.
Free Valuable Insights: The Intraosseous Infusion Devices Market is Predict to reach USD 1.4 Billion by 2031, at a CAGR of 5.9%
Based on Devices Type, the market is segmented into Manual IO Needles, Battery Powered Driver and Impact Driven Devices. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
By Devices Type
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 